Margrett Priest Lewis – Trademark Portfolio

Entity Type: 01

Margrett Priest Lewis holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 5 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 2 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include BRAIN-FX, BIOASSIST, and IMMUNE-FX. The owner is based in Berkeley, CA.

808 Gilman Street

Berkeley, CA 94710

5 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Margrett Priest Lewis's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (5 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

35
Advertising & Business (2 filings)

Advertising; business management; business administration; office functions

Frequently Asked Questions

How many trademarks does Margrett Priest Lewis have?

Margrett Priest Lewis has 5 U.S. trademarks filed with the USPTO. Of these, 3 registered, 2 abandoned.

What trademark classes does Margrett Priest Lewis file in?

Margrett Priest Lewis files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 35 (Advertising & Business). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are Margrett Priest Lewis's most well-known trademarks?

Margrett Priest Lewis's registered trademark portfolio includes well-known marks such as BRAIN-FX, BIOASSIST, and IMMUNE-FX. These are among 3 currently registered trademarks in the portfolio.

What is Margrett Priest Lewis's trademark registration success rate?

Margrett Priest Lewis has a 60% trademark registration rate, with 3 out of 5 resolved applications resulting in successful registration. Currently, 0 applications are pending review.